Pages that link to "Q28118306"
Jump to navigation
Jump to search
The following pages link to TIGAR, a p53-inducible regulator of glycolysis and apoptosis (Q28118306):
Displaying 50 items.
- TP53 induced glycolysis regulatory phosphatase (Q21122857) (← links)
- Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology (Q21129303) (← links)
- Autophagy in idiopathic pulmonary fibrosis (Q21134133) (← links)
- Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited (Q21202785) (← links)
- The transcription factor p53: not a repressor, solely an activator (Q24273295) (← links)
- Phosphofructokinase 1 glycosylation regulates cell growth and metabolism (Q24297510) (← links)
- p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway (Q24297735) (← links)
- Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells (Q24299676) (← links)
- Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death (Q24305032) (← links)
- Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species (Q24305112) (← links)
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function (Q24306243) (← links)
- Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis (Q24313608) (← links)
- Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator) (Q24315699) (← links)
- ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair (Q24316319) (← links)
- Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation (Q24323390) (← links)
- The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation (Q24336894) (← links)
- TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway (Q24337162) (← links)
- Applications of metabolomics in cancer research (Q24600728) (← links)
- Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH (Q24603767) (← links)
- Understanding the Warburg effect: the metabolic requirements of cell proliferation (Q24604760) (← links)
- Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling (Q24608960) (← links)
- Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death (Q24610879) (← links)
- Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment (Q24611183) (← links)
- Human pyruvate kinase M2: a multifunctional protein (Q24625882) (← links)
- Links between metabolism and cancer (Q24626229) (← links)
- Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor (Q24631421) (← links)
- Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation (Q24643422) (← links)
- Modulation of intracellular ROS levels by TIGAR controls autophagy (Q24644257) (← links)
- Redox-directed cancer therapeutics: molecular mechanisms and opportunities (Q24645584) (← links)
- Brick by brick: metabolism and tumor cell growth (Q24656187) (← links)
- Two faces of p53: aging and tumor suppression (Q24681014) (← links)
- Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells (Q24683296) (← links)
- Targeting Cancer Metabolism - Revisiting the Warburg Effects (Q26738876) (← links)
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy (Q26740191) (← links)
- Mitochondria, cholesterol and cancer cell metabolism (Q26741708) (← links)
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways (Q26742114) (← links)
- Metabolic, autophagic, and mitophagic activities in cancer initiation and progression (Q26745503) (← links)
- DNA Tumor Viruses and Cell Metabolism (Q26749066) (← links)
- Hepatocellular carcinoma: Review of disease and tumor biomarkers (Q26750796) (← links)
- Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders? (Q26766062) (← links)
- The sweet trap in tumors: aerobic glycolysis and potential targets for therapy (Q26766079) (← links)
- Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy (Q26766341) (← links)
- Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways (Q26767396) (← links)
- The Warburg effect and drug resistance (Q26770007) (← links)
- Hypoxia and metabolic adaptation of cancer cells (Q26774856) (← links)
- Dysregulated metabolism contributes to oncogenesis (Q26784630) (← links)
- The Impact of Non-Enzymatic Reactions and Enzyme Promiscuity on Cellular Metabolism during (Oxidative) Stress Conditions (Q26785889) (← links)
- Energy metabolism plasticity enables stemness programs (Q26822945) (← links)
- Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies (Q26823118) (← links)